Cures Act Is Bad Medicine for NIH, FDA

A bipartisan bill that promises more money for research and development is actually full of giveaways for the pharmaceutical industry and other trade groups.

by

The American Prospect depends on reader support

If you are scraping by right now, please don’t give us anything. But if you have the ability to support independent, non-profit journalism, we are so grateful. Your voluntary contribution helps keep this website paywall-free. You can sign up as a subscriber with a range of benefits, including an opt-in to receive the print magazine by mail.

Click to View Subscriber Levels: IDEAS, POLITICS & POWER